Made life dangerous for manchild Bill on several occasions.

Conscientiously working my way through a Chi Trib editorial about the cost of a new “wonder” drug, I found myself working too hard.

There’s a new breakthrough hepatitis C drug treatment that cures — yes, cures — almost everyone who takes it. Unlike previous, far less effective treatments, patients suffer few if any side effects. The entire regimen takes only 12 weeks, much shorter than previous regimens.

The drug, Sovaldi, could save the lives of many of the estimated 80,000 people a year who die from the blood-borne liver disease. Eventually, Sovaldi could save the nation’s health system billions of dollars by preventing liver failure and liver cancer, not to mention curbing the huge costs of liver transplants.

And which blood-born liver disease is that? Oh sure, I can figure it out, hepatitis C, backtracking to solve the little puzzle the writer puts in my way. What do you think I am, stupid?

No, but I would rather move right along, In this wise:

“The drug could save the lives of many who die from hepatitis C, which is a blood-born liver disease.”

Better yet, I could have been informed at the start:

“There’s a breakthrough [not new: breakthroughs are never old] drug treatment for the blood-borne liver disease hepatitis-C,” etc.

Breakthrough is the point. A lot of us don’t know hepatitis-C from A or B, and of course we don’t like puzzles in editorials.